|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9,337.00 JPY | +1.82% |
|
+1.49% | +13.27% |
| 06/02 | Japan's Nikkei rallies on earnings in unsteady trade before Sunday election | RE |
| 06/02 | Japanese drugmakers slump after Trump unveils discount drug website | RE |
| Capitalization | 15,09100Cr 9.82TCr 8.31TCr 7.59TCr 7.26TCr 13TCr 8,90500Cr 14TCr 88TCr 35TCr 4,29600Cr 37TCr 36TCr | P/E ratio 2025 |
31.3x | P/E ratio 2026 * | 31.2x |
|---|---|---|---|---|---|
| Enterprise value | 14,19500Cr 9.24TCr 7.81TCr 7.14TCr 6.83TCr 13TCr 8,37700Cr 13TCr 83TCr 33TCr 4,04000Cr 35TCr 34TCr | EV / Sales 2025 |
10.4x | EV / Sales 2026 * | 10.5x |
| Free-Float |
38.09% | Yield 2025 |
3.3% | Yield 2026 * | 1.53% |
Last Transcript: Chugai Pharmaceutical Co., Ltd.
| 1 day | +1.82% | ||
| 1 week | +1.49% | ||
| Current month | +6.09% | ||
| 1 month | +13.48% | ||
| 3 months | +12.49% | ||
| 6 months | +49.15% | ||
| Current year | +13.27% |
| 1 week | 9,038 | 9,342 | |
| 1 month | 8,168 | 9,460 | |
| Current year | 8,168 | 9,460 | |
| 1 year | 5,942 | 9,460 | |
| 3 years | 3,203 | 9,460 | |
| 5 years | 3,191 | 9,460 | |
| 10 years | 1,003.33 | 9,460 |
| Manager | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 62 | 01/01/2021 |
Iwaaki Taniguchi
DFI | Director of Finance/CFO | - | 28/03/2024 |
Junichi Nezu
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Motoo Ueno
BRD | Director/Board Member | 68 | 01/03/1993 |
Masayuki Oku
BRD | Director/Board Member | 81 | 01/03/2015 |
| Director/Board Member | 77 | 01/03/2017 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.82% | +1.49% | +26.11% | +161.54% | 9.95TCr | ||
| -0.38% | +1.08% | +22.72% | +215.48% | 93TCr | ||
| -0.05% | +2.09% | +55.83% | +51.71% | 59TCr | ||
| +0.59% | +4.68% | +20.73% | +53.90% | 41TCr | ||
| +2.16% | +5.16% | +25.45% | +32.23% | 38TCr | ||
| +2.39% | +9.59% | +32.51% | +35.14% | 32TCr | ||
| +1.52% | +6.10% | +34.09% | +59.90% | 31TCr | ||
| +0.13% | +3.77% | +46.45% | +11.00% | 30TCr | ||
| +0.73% | -1.60% | -45.57% | -37.14% | 22TCr | ||
| +1.13% | +2.39% | +28.23% | +55.22% | 20TCr | ||
| Average | +1.00% | +2.67% | +24.65% | +63.90% | 37.51TCr | |
| Weighted average by Cap. | +0.67% | +2.55% | +28.08% | +84.52% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 1,24700Cr 811.71Cr 686.3Cr 626.75Cr 600.01Cr 1.11TCr 74TCr 1.15TCr 7.31TCr 2.9TCr 35TCr 3.04TCr 2.98TCr | 1,34200Cr 873.73Cr 738.74Cr 674.64Cr 645.86Cr 1.19TCr 79TCr 1.24TCr 7.87TCr 3.12TCr 38TCr 3.28TCr 3.21TCr |
| Net income | 43TCr 278.69Cr 235.63Cr 215.19Cr 206.01Cr 380.58Cr 25TCr 394.54Cr 2.51TCr 994.08Cr 12TCr 1.05TCr 1.02TCr | 48TCr 315.08Cr 266.4Cr 243.29Cr 232.91Cr 430.28Cr 29TCr 446.06Cr 2.84TCr 1.12TCr 14TCr 1.18TCr 1.16TCr |
| Net Debt | -90TCr -583.41Cr -493.28Cr -450.48Cr -431.26Cr -796.73Cr -53TCr -825.94Cr -5.25TCr -2.08TCr -26TCr -2.19TCr -2.14TCr | -1,03100Cr -671.15Cr -567.46Cr -518.23Cr -496.12Cr -916.55Cr -61TCr -950.15Cr -6.05TCr -2.39TCr -29TCr -2.52TCr -2.47TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/26/18 | 9,337.00 ¥ | +1.82% | 5,45,700 |
| 17/26/17 | 9,170.00 ¥ | -1.21% | 21,14,200 |
| 16/26/16 | 9,282.00 ¥ | +0.02% | 15,26,100 |
| 13/26/13 | 9,280.00 ¥ | +0.87% | 34,29,500 |
| 12/26/12 | 9,200.00 ¥ | +1.97% | 23,81,100 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4519 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition

















